PPSG
GSK icon

Princeton Portfolio Strategies Group’s GSK GSK Stock Holding History

Princeton Portfolio Strategies Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$916K Buy
18,394
+1,080
+6% +$51.9K 0.18% 97
2021
Q1 		$772K Buy
17,314
+800
+5% +$36.3K 0.15% 107
2020
Q4 		$760K Buy
16,514
+4,800
+41% +$220K 0.15% 107
2020
Q3 		$551K Sell
11,714
-640
-5% -$32.1K 0.12% 110
2020
Q2 		$630K Hold
12,354
– – 0.15% 104
2020
Q1 		$585K Hold
12,354
– – 0.17% 96
2019
Q4 		$726K Hold
12,354
– – 0.17% 101
2019
Q3 		$659K Hold
12,354
– – 0.16% 99
2019
Q2 		$618K Sell
12,354
-32
-0.3% -$1.61K 0.16% 106
2019
Q1 		$647K Sell
12,386
-400
-3% -$20K 0.17% 107
2018
Q4 		$611K Buy
12,786
+400
+3% +$19.7K 0.19% 104
2018
Q3 		$622K Sell
12,386
-1,905
-13% -$96.8K 0.16% 110
2018
Q2 		$720K Sell
14,291
-8,530
-37% -$430K 0.21% 101
2018
Q1 		$1.11M Sell
22,821
-385
-2% -$17.9K 0.32% 84
2017
Q4 		$1.03M Sell
23,206
-1,916
-8% -$88.5K 0.28% 90
2017
Q3 		$1.27M Buy
25,122
+485
+2% +$24.6K 0.35% 76
2017
Q2 		$1.33M Buy
24,637
+1,286
+6% +$68.6K 0.38% 74
2017
Q1 		$1.23M Buy
23,351
+1,605
+7% +$81.4K 0.37% 74
2016
Q4 		$1.05M Buy
21,746
+6,160
+40% +$304K 0.33% 77
2016
Q3 		$840K Sell
15,586
-676
-4% -$37.1K 0.26% 84
2016
Q2 		$881K Buy
16,262
+2,460
+18% +$130K 0.28% 86
2016
Q1 		$700K Buy
13,802
+200
+1% +$9.96K 0.24% 92
2015
Q4 		$686K Buy
13,602
+480
+4% +$24.5K 0.24% 89
2015
Q3 		$631K Buy
13,122
+9,062
+223% +$472K 0.26% 80
2015
Q2 		$211K Buy
+4,060
New +$229K 0.07% 132

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Princeton Portfolio Strategies Group's GSK Position: Q2 2021 in Review

Princeton Portfolio Strategies Group increased its GSK (GSK) stake by 6.2% in Q2 2021, buying an estimated $51.9K and bringing the position to 18,394 shares worth $916K. The position accounts for 0.18% of the portfolio, ranked #97.

Princeton Portfolio Strategies Group first reported a position in GSK in Q2 2015 and has held it in 25 quarters since. The position peaked at $1.33M in Q2 2017. 798 funds tracked by Wall St. Rank hold GSK as of Q2 2021.

  • Princeton Portfolio Strategies Group held 18,394 shares of GSK worth $916K as of Q2 2021.
  • Princeton Portfolio Strategies Group bought 1,080 GSK shares in Q2 2021, an estimated $51.9K.
  • GSK made up 0.18% of Princeton Portfolio Strategies Group's portfolio in Q2 2021, its #97 holding.
  • Princeton Portfolio Strategies Group first reported a position in GSK in Q2 2015 and has held it in 25 quarters since.
  • Princeton Portfolio Strategies Group's GSK position peaked at $1.33M in Q2 2017.
  • 798 funds tracked by Wall St. Rank held GSK as of Q2 2021.

Based on Princeton Portfolio Strategies Group's 13F filing for Q2 2021, filed 2 Aug 2021.